For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Single-dose Thymoglobulin | Biological/Vaccine Single-dose rabbit Anti-thymocyte Globulin induction, 6 mg/kg IV infusion Single-dose rabbit Anti-thymocyte Globulin induction: 6 mg of rATG administered in a single dose on the day of kidney transplantation | None | None | 23 | 44 | 44 | 44 | View |
| Divided-dose Thymoglobulin | Biological/Vaccine Divided-dose rabbit Anti-thymocyte Globulin induction, 1.5 mg/kg IV infusion QD x 4 Divided-dose rabbit Anti-thymocyte Globulin induction: 6 mg/kg total rabbit Anti-thymocyte Globulin dose administered as 1.5 mg/kg doses on 4 sequential days, beginning on the day of kidney transplantation. | None | None | 21 | 51 | 49 | 51 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| serum sickness | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| atrial fibrillation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Myocardial infarction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Congestive heart failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Atypical chest pain | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| hyperkalemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| abdominal fullness | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| death | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| orthostatic hypotension | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| cholangitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| hepatitis C exposure | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Leukopenia | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| BK virus | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| C. difficile | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Histoplasmosis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Influenza | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Viral Gasteroenteritis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| rATG reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Chronic lymphoid leukemia | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Basal cell carcinoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Prostate cancer | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Seizures | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Acute tubular necrosis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Delayed graft function | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Interstitial nephritis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Native nephrectomy | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Nephrostomy tube placement | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Perinephric hematoma | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Rejection | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Renal vein thrombosis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Urinary retention | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pneumothorax | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Wound hernia repair | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hemorrhage | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Hyperparathyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Hyperphosphatemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Hypomagnesemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Osteopenia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastric reflux | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Edema | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Orthostatic hypotension | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Tacrolimus elevation/toxicity | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Elevated liver enzymes | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Leukocytosis | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Leukopenia | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Neutropenia | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| BK virus | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pancytopenia | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| C. difficile | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Respiratory infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Possible rATG reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Metabolic acidosis | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperlipidemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Tremor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dysuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Elevated serum creatinine | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Rejection | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Shortness of breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pruritis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hernia | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Wound complication | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |